If Shares of Personalis (PSNL) Trade Above This Level, Expect a Breakout

Shares of Personalis (PSNL – Get Rating) could see a strong move higher soon.  That’s because a key resistance level has formed on the stock’s chart.

PSNL is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies.

The company received some good news last week as the U.S. Department of Veterans Affairs Million Veteran Program exercised its option to extend PSNL’s existing contract through September 2021 and issued a new order worth up to $31 million.

Continue reading at STOCKNEWS.com